Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021

BUY
$129.91 - $234.98 $719,051 - $1.3 Million
5,535 New
5,535 $1.3 Million
Q1 2021

Apr 27, 2021

SELL
$109.18 - $185.98 $413,246 - $703,934
-3,785 Closed
0 $0
Q4 2020

Jan 20, 2021

BUY
$65.74 - $169.86 $248,825 - $642,920
3,785 New
3,785 $395,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Tuttle Capital Management, LLC Portfolio

Follow Tuttle Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tuttle Capital Management, LLC with notifications on news.